Welch Group Raised Its Holding in Abbvie Com Usd0.01 (ABBV) by $303,150; Intuit (INTU) Stock Price Declined While Comgest Global Investors Sas Has Trimmed Stake

AbbVie Inc. (NYSE:ABBV) Logo

Comgest Global Investors Sas decreased its stake in Intuit (INTU) by 14.98% based on its latest 2018Q3 regulatory filing with the SEC. Comgest Global Investors Sas sold 79,500 shares as the company’s stock declined 7.98% with the market. The institutional investor held 451,176 shares of the prepackaged software company at the end of 2018Q3, valued at $102.60M, down from 530,676 at the end of the previous reported quarter. Comgest Global Investors Sas who had been investing in Intuit for a number of months, seems to be less bullish one the $53.48 billion market cap company. The stock increased 1.68% or $3.4 during the last trading session, reaching $206.06. About 1.51 million shares traded. Intuit Inc. (NASDAQ:INTU) has risen 32.93% since January 11, 2018 and is uptrending. It has outperformed by 32.93% the S&P500. Some Historical INTU News: 27/03/2018 – MOODY’S UPGRADES INTUIT SR UNSECURED TO A3 FROM Baa1; 24/05/2018 – Cramer also hears from the CEOs of Indigo Agriculture and Intuit; 25/04/2018 – INTUIT REPORTS 6% BOOST IN TURBOTAX ONLINE UNITS:; 22/05/2018 – INTUIT INC – SEES FULL FISCAL YEAR 2018 GAAP DILUTED EARNINGS PER SHARE OF $4.50 TO $4.52; 17/05/2018 – SF Business Times: Exclusive: #HRtech company @glintinc adds @Intuit / $INTU exec as its first independent board member; 06/04/2018 – Intuit Closes Below 50-Day Moving Average: Technicals; 22/05/2018 – INTUIT INC – QTRLY REVENUE $2.925 BLN, UP 15 PERCENT; 27/03/2018 – Moody’s Upgrades Intuit Senior Unsecured To A3; Outlook Stable; 07/03/2018 – Medfusion Launches its Newest Patient Experience Platform at HIMSS18; 20/04/2018 – DJ Intuit Inc, Inst Holders, 1Q 2018 (INTU)

Welch Group Llc increased its stake in Abbvie Inc Com Usd0.01 (ABBV) by 1.16% based on its latest 2018Q3 regulatory filing with the SEC. Welch Group Llc bought 3,225 shares as the company’s stock declined 6.62% with the market. The institutional investor held 282,216 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $26.69M, up from 278,991 at the end of the previous reported quarter. Welch Group Llc who had been investing in Abbvie Inc Com Usd0.01 for a number of months, seems to be bullish on the $132.67B market cap company. The stock increased 0.44% or $0.39 during the last trading session, reaching $88.2. About 6.53M shares traded. AbbVie Inc. (NYSE:ABBV) has declined 7.04% since January 11, 2018 and is downtrending. It has underperformed by 7.04% the S&P500. Some Historical ABBV News: 08/05/2018 – J&J’s Janssen: Darzalex Is the First Monoclonal Antibody Approved for Newly Diagnosed Patients With Newly Diagnosed Multiple Myeloma; 25/05/2018 – Oncolytics Biotech® Announces Research Collaboration with the Keck School of Medicine of USC Combining REOLYSIN® with Keytruda®, Velcade® and Dexamethasone; 26/04/2018 – AbbVie to Commence Self-Tender Offer for Up to $7.5B of Common Stk; 01/05/2018 – AbbVie: Tender Offer and Withdrawal Rights Will Expire at Midnight ET May 29, 2018; 25/04/2018 – ABBVIE SUBMITS BLA TO FDA FOR RISANKIZUMAB; 05/04/2018 – BIOGEN INC – COMPANIES HAVE AGREED TO DISMISS ALL PENDING PATENT LITIGATION; 05/04/2018 – Samsung Bioepis Settles Patent Disputes with AbbVie, Clearing the Way for the Commercialization of SB5 (Adalimumab) in All Approved Markets Worldwide; 25/05/2018 – ASTRAZENECA PLC AZN.L – IMFINZI SIGNIFICANTLY IMPROVES OVERALL SURVIVAL IN PHASE lll; 21/03/2018 – AbbVie and the International Myeloma Foundation Announce Partnership to Study the Role of a Genetic Mutation in Outcomes of Patients with Multiple Myeloma; 02/04/2018 – Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients With Pegzilarginase in Both Monotherapy and KEYTRUDA Combination Trials

Among 26 analysts covering Intuit (NASDAQ:INTU), 14 have Buy rating, 4 Sell and 8 Hold. Therefore 54% are positive. Intuit had 122 analyst reports since August 10, 2015 according to SRatingsIntel. On Wednesday, October 4 the stock rating was maintained by Stifel Nicolaus with “Hold”. The rating was maintained by Jefferies with “Buy” on Friday, September 18. Oppenheimer maintained Intuit Inc. (NASDAQ:INTU) on Thursday, August 25 with “Outperform” rating. The firm earned “Sell” rating on Tuesday, May 22 by First Analysis. The stock of Intuit Inc. (NASDAQ:INTU) earned “Buy” rating by Oppenheimer on Friday, October 27. The firm earned “Buy” rating on Sunday, April 22 by Jefferies. The rating was maintained by Bank of America on Tuesday, May 1 with “Buy”. Credit Suisse maintained Intuit Inc. (NASDAQ:INTU) on Friday, September 28 with “Outperform” rating. As per Thursday, September 10, the company rating was upgraded by Barclays Capital. The rating was maintained by Credit Suisse with “Neutral” on Wednesday, August 24.

More notable recent Intuit Inc. (NASDAQ:INTU) news were published by: Nasdaq.com which released: “The Implied Analyst 12-Month Target For USMV – Nasdaq” on December 26, 2018, also Nasdaq.com with their article: “Notable Two Hundred Day Moving Average Cross – INTU – Nasdaq” published on December 14, 2018, Seekingalpha.com published: “Intuit: Unlocking Growth Opportunity Through Xero Acquisition – Seeking Alpha” on December 27, 2018. More interesting news about Intuit Inc. (NASDAQ:INTU) were released by: Nasdaq.com and their article: “Intuit (INTU) to Report Q1 Earnings: What’s in the Cards? – Nasdaq” published on November 14, 2018 as well as Seekingalpha.com‘s news article titled: “Intuit: Why Are Executives Leaving? – Seeking Alpha” with publication date: August 30, 2018.

Since August 27, 2018, it had 0 insider buys, and 15 sales for $192.53 million activity. FLOURNOY MARK J sold 9,292 shares worth $2.03 million. 254,325 Intuit Inc. (NASDAQ:INTU) shares with value of $57.90M were sold by SMITH BRAD D. 4,554 shares were sold by POWELL DENNIS D, worth $979,360. Shares for $16.89 million were sold by Goodarzi Sasan K on Wednesday, November 21. Shares for $1.44 million were sold by STANSBURY HENRY TAYLOE on Tuesday, November 27. Shares for $1.01 million were sold by Johnson Gregory N.

Investors sentiment decreased to 1.12 in 2018 Q3. Its down 0.13, from 1.25 in 2018Q2. It turned negative, as 24 investors sold INTU shares while 257 reduced holdings. 97 funds opened positions while 219 raised stakes. 215.92 million shares or 0.30% more from 215.26 million shares in 2018Q2 were reported. Royal Bank & Trust Of Canada reported 1.14M shares. Shine Inv Advisory Services stated it has 0.09% in Intuit Inc. (NASDAQ:INTU). Blair William And Com Il accumulated 268,640 shares. Harvest Capital Mngmt Incorporated stated it has 2,010 shares or 0.14% of all its holdings. State Farm Mutual Automobile Ins Comm has invested 0.92% in Intuit Inc. (NASDAQ:INTU). Bremer National Association accumulated 1,320 shares or 0.08% of the stock. Sun Life Financial accumulated 708 shares or 0.03% of the stock. Ashfield Cap Lc has 9,793 shares for 0.25% of their portfolio. World owns 4.42 million shares. Anderson Hoagland And Co reported 13,462 shares or 1.73% of all its holdings. Ontario – Canada-based Highstreet Asset Management has invested 0.05% in Intuit Inc. (NASDAQ:INTU). Edgestream Prns Lp holds 18,562 shares or 0.72% of its portfolio. Guggenheim Capital Llc has 0.16% invested in Intuit Inc. (NASDAQ:INTU). Bankshares Of Nova Scotia holds 52,702 shares. United Kingdom-based Gsa Ptnrs Limited Liability Partnership has invested 0.12% in Intuit Inc. (NASDAQ:INTU).

Comgest Global Investors Sas, which manages about $4.46 billion US Long portfolio, upped its stake in Verisk Analytics Inc (NASDAQ:VRSK) by 5,700 shares to 71,900 shares, valued at $8.67M in 2018Q3, according to the filing. It also increased its holding in United Technologies Corp (NYSE:UTX) by 4,000 shares in the quarter, for a total of 32,000 shares, and has risen its stake in Ecolab Inc (NYSE:ECL).

Analysts await Intuit Inc. (NASDAQ:INTU) to report earnings on February, 28. They expect $0.57 EPS, up 612.50% or $0.49 from last year’s $0.08 per share. INTU’s profit will be $147.94M for 90.38 P/E if the $0.57 EPS becomes a reality. After $-0.03 actual EPS reported by Intuit Inc. for the previous quarter, Wall Street now forecasts -2,000.00% EPS growth.

Among 26 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 3 Sell and 13 Hold. Therefore 38% are positive. Abbvie Inc had 105 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was downgraded by PiperJaffray to “Neutral” on Friday, June 1. Cowen & Co maintained it with “Buy” rating and $130.0 target in Friday, January 26 report. The stock of AbbVie Inc. (NYSE:ABBV) earned “Underperform” rating by BMO Capital Markets on Monday, November 5. The firm has “Sell” rating by Credit Suisse given on Friday, June 22. Barclays Capital maintained AbbVie Inc. (NYSE:ABBV) rating on Thursday, April 5. Barclays Capital has “Equal-Weight” rating and $102 target. The firm earned “Hold” rating on Wednesday, April 19 by BMO Capital Markets. The rating was maintained by Morgan Stanley on Tuesday, January 30 with “Equal-Weight”. The stock of AbbVie Inc. (NYSE:ABBV) has “Market Perform” rating given on Thursday, November 16 by BMO Capital Markets. The company was maintained on Monday, October 30 by Leerink Swann. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Argus Research on Tuesday, November 6.

Since August 17, 2018, it had 0 insider purchases, and 6 insider sales for $26.66 million activity. On Wednesday, December 12 CHASE WILLIAM J sold $5.40 million worth of AbbVie Inc. (NYSE:ABBV) or 60,000 shares. 16,850 shares were sold by GONZALEZ RICHARD A, worth $1.50 million on Tuesday, December 11. On Thursday, November 29 the insider Gosebruch Henry O sold $3.82M. On Friday, August 17 the insider SEVERINO MICHAEL sold $4.88 million.

Investors sentiment decreased to 0.82 in Q3 2018. Its down 0.12, from 0.94 in 2018Q2. It dived, as 60 investors sold ABBV shares while 637 reduced holdings. 107 funds opened positions while 466 raised stakes. 994.12 million shares or 0.91% less from 1.00 billion shares in 2018Q2 were reported. Alpha Windward Lc, Massachusetts-based fund reported 3,464 shares. Marathon Capital Mngmt invested in 0.09% or 2,361 shares. Paradigm Asset Company Limited Liability Corp holds 10,900 shares or 0% of its portfolio. Mitsubishi Ufj Hldg Ltd reported 470 shares or 0.14% of all its holdings. Signaturefd Llc owns 13,660 shares for 0.13% of their portfolio. Pittenger And Anderson stated it has 27,000 shares. Convergence Inv Prtn Lc holds 1.3% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 67,176 shares. 28,469 were accumulated by Norris Perne French Ltd Liability Partnership Mi. Wms Limited Liability Com holds 0.13% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 12,025 shares. Peavine Cap Lc accumulated 21,600 shares. 30,125 are owned by Ontario Teachers Pension Plan Board. Crawford Invest Counsel has invested 0.07% in AbbVie Inc. (NYSE:ABBV). Cap Fund Sa holds 0.76% or 1.47M shares. Moody Savings Bank Trust Division holds 130,598 shares or 0.31% of its portfolio. First Commonwealth Pa holds 4,727 shares or 0.3% of its portfolio.

Welch Group Llc, which manages about $645.12M and $960.13 million US Long portfolio, decreased its stake in Home Depot Inc (NYSE:HD) by 1,640 shares to 143,902 shares, valued at $29.81M in 2018Q3, according to the filing.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “AbbVie teams up with Voluntis in companion digital therapeutics – Seeking Alpha” on December 19, 2018, also Seekingalpha.com with their article: “Pfizer withdraws European marketing application for Humira biosimilar – Seeking Alpha” published on December 14, 2018, Seekingalpha.com published: “AbbVie – Stemcentrx Impairment, A Worrying Sign? – Seeking Alpha” on January 10, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “FDA to “take action” against branded drug makers using scare tactics to thwart biosimilar competition – Seeking Alpha” published on January 10, 2019 as well as Seekingalpha.com‘s news article titled: “60 Minutes to air piece on opioid drugmakers and distributors Sunday – Seeking Alpha” with publication date: December 14, 2018.

Intuit Inc. (NASDAQ:INTU) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.